Search

Abstract Over the past years, poly(lactic acid) or polylactide (PLA) is commonly researched as a possible replacement for traditional fossil‐based polymers because of its compostability, biocompatibility, and high mechanical properties. PLA has a variety of applications in packaging, biomedical, and structural. However, PLA has limitations, such as high brittleness, low thermal stability, and a slow crystallization rate, which limits the wide range of applications. To overcome these limitations, the literature reports that blending PLA with other polymers, such as poly(ε‐caprolactone) (PCL), is an economically viable approach. Although blending PLA with PCL is considered a feasible approach, the blend system still suffers from immiscibility, depending on the blend composition. This review aims to highlight recent developments from 2014 to date on the processing of PLA/PCL blends, including their composites, with a primary focus on morphological characteristics and mechanical and thermal properties, including their potential applications in various sectors.

Abstract Polycaprolactone (PCL) is one of the durable polymers with potential in a plethora of healthcare applications. Its biological properties, degradability, chemical properties, and mechanical properties can further be modified to manufacture desired products for modern biomedical applications. Electrospinning of PCL offers the opportunity to design treatment materials that resemble human tissues and facilitate regeneration at the target site. The resultant materials can also be modified by loading other active functional materials to broaden their applications. Herein, the recent advances in the preparation and modification of PCL‐based materials for healthcare applications are elucidated. The challenges and future trends for its application in modern biomedical applications are also outlined.

In this paper, we report the synthesis of a multi-template molecularly imprinted polymer (MIP) to target and extract naproxen, ibuprofen, diclofenac, emtricitabine, tenofovir disoproxil, and efavirenz from wastewater bodies. A bulk polymerization procedure was used to synthesize the MIP and non-imprinted polymer (NIP). The specific recognition sites for each target were obtained through the removal of the imprinted targeted compounds. The interaction of antiretroviral drugs (ARVs) and non-steroidal anti-inflammatory drugs (NSAIDs) compounds with the MIP was studied under various conditions such as pH, mass, concentration, and time factors. The results demonstrated the optimum conditions were 55 mg of MIP, pH 7.0, a concentration of 5 mg L−1, and a contact time of 10 min. For every compound studied, the extraction efficiencies for ARVs and NSAIDs in aqueous solutions was >96%. The adsorption capacity for the MIP was >0.91 mg·g−1. Adsorption obeys a second-order rate, and the Freundlich model explains the adsorption isotherm data. This study demonstrated that the synthesized multi-template MIP has huge potential to be employed for the removal of ARVs and NSAIDs from the environment as well as in drug purification or recovery processes.